Centre for Health Research and Development, Society for Applied Studies, New Delhi, India.
DBT/Wellcome India Alliance Clinical and Public health Fellow, Hyderabad, India.
Pediatrics. 2022 Aug 1;150(Suppl 1). doi: 10.1542/peds.2022-057092N.
To assess effects of supplementation with 3 or more micronutrients (multiple micronutrients; MMN) compared to no MMN in human milk-fed preterm and low birth weight (LBW) infants.
Data on a subgroup of 414 preterm or LBW infants from 2 randomized controlled trials (4 reports) were included. The certainty of evidence ranged from low to very low. For growth outcomes in the MMN compared to the non-MMN group, there was a small increase in weight-for-age (2 trials, 383 participants) and height-for-age z-scores (2 trials, 372 participants); a small decrease in wasting (2 trials, 398 participants); small increases in stunting (2 trials, 399 participants); and an increase in underweight (2 trials, 396 participants). For neurodevelopment outcomes at 78 weeks, we found small increases in Bayley Scales of Infant Development, Version III (BISD-III), scores (cognition, receptive language, expressive language, fine motor, gross motor) in the MMN compared to the non-MMN group (1 trial, 27 participants). There were no studies examining dose or timing of supplementation.
Evidence is insufficient to determine whether enteral MMN supplementation to preterm or LBW infants who are fed mother's own milk is associated with benefit or harm. More trials are needed to generate evidence on mortality, morbidity, growth, and neurodevelopment.
评估与不补充多种微量营养素(MMN)相比,人乳喂养的早产儿和低出生体重(LBW)婴儿补充 3 种或更多种微量营养素(MMN)的效果。
纳入了 2 项随机对照试验(4 份报告)中 414 名早产儿或 LBW 婴儿的亚组数据。证据的确定性范围从低到极低。对于 MMN 组与非 MMN 组的生长结局,体重与年龄比(2 项试验,383 名参与者)和身高与年龄比 z 评分(2 项试验,372 名参与者)略有增加;消瘦(2 项试验,398 名参与者)略有减少;发育迟缓(2 项试验,399 名参与者)略有增加;体重不足(2 项试验,396 名参与者)增加。对于 78 周的神经发育结局,我们发现与非 MMN 组相比,MMN 组的贝利婴幼儿发育量表第三版(BISD-III)评分(认知、接受性语言、表达性语言、精细运动、粗大运动)略有增加(1 项试验,27 名参与者)。没有研究检查补充剂的剂量或时间。
目前证据不足以确定对母乳喂养的早产儿或 LBW 婴儿进行肠内 MMN 补充是否有益或有害。需要更多的试验来产生关于死亡率、发病率、生长和神经发育的证据。